170514 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Assays involving non-enzymic blood coagulation factors
Sub-classes:METHOD FOR DETECTING THE PRESENCE, IDENTIFICATION AND QUANTIFICATION IN A BLOOD SAMPLE OF ANTICOAGULANTS WHICH ARE BLOOD COAGULATION ENZYMES INHIBITORS, AND MEANS FOR THE IMPLEMENTATION THEREOF
#2PROGNOSTIC AND DIAGNOSTIC METHODS FOR RISK OF ACUTE KIDNEY INJURY
#3FACTOR Xa REAGENT
#4METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS
#5Methods and monitoring of treatment with lanifibranor
#6IN VITRO MEASUREMENT OF THE LYSIS OF A FIBRIN CLOT
#7PHOTOREACTIVE ANTIBODY BINDING DOMAINS WITH EPITOPE TAGS FOR MULTIPLEXED ANTIBODY LABELING, DETECTION, AND PURIFICATION
#8Biomarker for Regulatory T Cell
#9Blood Test to Screen Out Parkinson's Disease
#10Precision Medicine Approach to Targeting Neurodegeneration
#11METHOD FOR EVALUATING BLOOD PARAMETERS
#12METHODS AND SYSTEMS FOR RISK STRATIFICATION AND MANAGEMENT OF BLADDER CANCER
#13METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH INTENSE STRESS
#14Marker polypeptide of bothrops atrox-like thrombin and method thereof for detecting species source and content of snake venom-like thrombin and application
#15NEW BINDING AGENT AND ASSAY FOR PIVKA
#16DEVICES AND METHODS FOR DETERMINING COAGULATION FACTOR ACTIVITIES
#17METHOD FOR DETERMINING THE RISK OF A THROMBOEMBOLIC EVENT
#18METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS
#19PROGNOSTIC AND DIAGNOSTIC METHODS FOR RISK OF ACUTE KIDNEY INJURY
#20EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS
#21SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#22METHOD FOR DETECTING THE PRESENCE, IDENTIFICATION AND QUANTIFICATION IN A BLOOD SAMPLE OF ANTICOAGULANTS WHICH ARE BLOOD COAGULATION ENZYMES INHIBITORS, AND MEANS FOR THE IMPLEMENTATION THEREOF
#23IMMUNOASSAY TO DETECT CLEAVED HIGH MOLECULAR WEIGHT KININOGEN
#24Diagnosis and treatment of autoimmune diseases
#25SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#26SINGLE CHANNEL CARTRIDGE DEVICE FOR COAGULATION ASSAYS IN FLUID SAMPLES
#27Incrementally optimized pharmacokinetic and pharmacodynamic model
#28Binding agent and assay for PIVKA
#29PIVKA-II MEASUREMENT METHOD, MEASUREMENT REAGENT, AND MEASUREMENT KIT
#30Identification of anticoagulants in a sample
#31ASSAY KIT AND METHOD FOR DETECTING MODULATORS OF GPIB-THROMBIN INTERACTION
#32Qualitative predictive method for differential diagnosis of pneumococcal, meningococcal and viral meningitis, method and kit for differential diagnosis of meningitis
#33TFPI inhibitors and methods of use
#34Diagnosis and treatment of autoimmune diseases
#35Single channel cartridge device for coagulation assays in fluid samples
#36Platelet biomarkers and diagnostic methods for vascular diseases
#37CARTRIDGE DEVICE WITH SEGMENTED FLUIDICS FOR ASSAYING COAGULATION IN FLUID SAMPLES
#38Immunoassay to detect cleaved high molecular weight kininogen
#39SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#40Chemiluminescence-based haemostasis assay
#41Methods for diagnosing and reducing incidences of cardiac allograft rejection
#42Method for preparation of thrombin
#43Container comprising haemoglobin fractions
#44COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER
#45Routine laboratory and point-of-care (POC) testing for hemostasis
#46TFPI inhibitors and methods of use
#47Qualitative predictive method for differential diagnosis of pneumococcal meningococcal and viral meningitis, method and kit for differential diagnosis of meningitis
#48METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS
#49METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#50Diagnosis and treatment of autoimmune diseases
#51Cartridge device with segmented fluidics for assaying coagulation in fluid samples
#52Methods of determining levels of cleaved and/or intact kininogen
#53Collagen-derived recombinant proteins with von Willebrand factor-binding activity
#54Method for detecting modulators of GPIb-thrombin interaction
#55PIVKA-II measurement method, measurement reagent, and measurement kit
#56Method of simultaneous detection of heparin-induced immunoglobulins types G, A, and M
#57Chemiluminescence-based haemostasis assay
#58TFPI inhibitors and methods of use
#59Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
#60Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
#61SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS
#62Method For Diagnosing Thrombophilia
#63TFPI inhibitors and methods of use
#64Homogeneous activity test for determining enzymatic reactions
#65SELECTION OF COLORECTAL CANCER PATIENTS FOR NEO-ADJUVANT AND ADJUVENT SYSTEMIC ANTI-CANCER TREATMENT
#66Modulation of Adenoviral Tropism
#67SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS
#68Method for quantitatively analyzing an anticoagulant in a sample
#69DIAGNOSTIC COMPOSITION AND ITS USE IN THE DETERMINATION OF COAGULATION CHARACTERISTICS OF A TEST LIQUID
#70DETECTION OF PHYSIOLOGICALLY ACCEPTABLE POLYMER MOLECULES USING NEAR INFRARED SPECTROSCOPY
#71Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
#72METHOD FOR ASSESSING THE FIBRINOGEN CONTRIBUTION IN COAGULATION
#73Biomarkers useful for diagnosing prostate cancer, and methods thereof
#74Methods and kits for detecting and measuring ADAMTS13/FXI complexes
#75METHOD FOR DIAGNOSING LIVER FIBROSIS
#76METHOD FOR DIAGNOSING LIVER FIBROSIS
#77Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
#78Membrane system for blood coagulation testing
#79Method of measuring binding site on plasma protein of plasma protein-binding drug and method of measuring plasma protein mutation
#80Method for diagnosis of thrombotic disorders
#81Kit for measuring the thrombin generation in a sample of a patient's blood or plasma